Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALEXION PHARMACEUTICALS, INC.

(ALXN)
  Report
SummaryQuotesChartsNewsRatingsCompanyFinancials 
Valuation
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Capitalization1 42 98127 43726 71821 72123 93334 173
Entreprise Value (EV)1 42 98127 43726 71821 72124 00734 105
P/E ratio 285x69,5x60,7x279x10,1x57,4x
Yield ------
Capitalization / Revenue 16,5x8,90x7,52x5,26x4,80x5,63x
EV / Revenue 16,5x8,90x7,52x5,26x4,80x5,63x
EV / EBITDA 51,2x23,5x18,4x10,9x9,59x10,7x
Price to Book ----2,12x2,94x
Nbr of stocks (in thousands) 225 324224 250223 410223 097221 291218 721
Reference price (USD) 19112212097,4108156
Announcement Date 02/08/201802/06/201902/04/202002/08/202102/08/202102/08/2021
1 USD in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Net sales1 2 6043 0843 5514 1314 9916 070
EBITDA1 8391 1671 4552 0002 4963 190
Operating profit (EBIT)1 6827939831 6202 1402 881
Operating Margin 26,2%25,7%27,7%39,2%42,9%47,5%
Pre-Tax Profit (EBT)1 4985765482422 179569
Net income1 14439944377,62 404603
Net margin 5,55%13,0%12,5%1,88%48,2%9,94%
EPS2 0,671,761,970,3510,72,72
Dividend per Share ------
Announcement Date 02/08/201802/06/201902/04/202002/08/202102/08/202102/08/2021
1 USD in Million
2 USD
Balance Sheet Analysis
Fiscal Period: December 2015 2016 2017 2018 2019 2020
Net Debt ----74,6-
Net Cash position -----68,0
Leverage (Debt / EBITDA) ----0,03x-0,02x
Free Cash Flow1 2925508691 0701 4012 111
ROE (Net Profit / Equities) 2,50%4,71%5,04%0,86%23,5%5,26%
Shareholders' equity1 5 7818 4768 7949 03010 21911 462
ROA (Net Profit / Asset) 4,93%3,76%4,58%7,36%8,50%10,1%
Assets1 2 92910 6129 6791 05428 2935 972
Book Value Per Share ----50,953,1
Cash Flow per Share ----12,113,5
Capex1 286333357213155107
Capex / Sales 11,0%10,8%10,1%5,16%3,10%1,76%
Announcement Date 02/08/201802/06/201902/04/202002/08/202102/08/202102/08/2021
1 USD in Million
Key data
Capitalization (USD) 40 336 009 475
Net sales (USD) 6 069 900 000
Number of employees 3 837
Sales / Employee (USD) 1 581 939
Free-Float 91,0%
Free-Float capitalization (USD) 36 685 890 155
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA